Study to Assess the Efficacy and Safety of Sitagliptin in Recently Diagnosed, Naive Type 2 Diabetics With Inadequate Glycemic Control on Diet and Exercise (0431-158)

Summary

After 24 weeks of treatment evaluate the efficacy and security.

Timeline

Start

2007-02-14

Primary completion

2008-07-11

Completion

2008-07-11

Drugs

Indications